MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5935/abc.20160072

Медицинская библиотека · Arquivos brasileiros de cardiologia · 2016

Transcatheter Aortic Valve Implantation and Morbidity and Mortality-Related Factors: a 5-Year Experience in Brazil.

Souza André Luiz Silveira, Salgado Constantino González, Mourilhe-Rocha Ricardo, Mesquita Evandro Tinoco, Lima Luciana Cristina Lima Correia, Mattos Nelson Durval Ferreira Gomes de, Rabischoffsky Arnaldo, Fagundes Francisco Eduardo Sampaio, Colafranceschi Alexandre Siciliano, Carvalho Luiz Antonio Ferreira

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Transcatheter aortic valve implantation has become an option for high-surgical-risk patients with aortic valve disease.

OBJECTIVE

To evaluate the in-hospital and one-year follow-up outcomes of transcatheter aortic valve implantation.

METHODS

Prospective cohort study of transcatheter aortic valve implantation cases from July 2009 to February 2015. Analysis of clinical and procedural variables, correlating them with in-hospital and one-year mortality.

RESULTS

A total of 136 patients with a mean age of 83 years (80-87) underwent heart valve implantation; of these, 49% were women, 131 (96.3%) had aortic stenosis, one (0.7%) had aortic regurgitation and four (2.9%) had prosthetic valve dysfunction. NYHA functional class was III or IV in 129 cases (94.8%). The baseline orifice area was 0.67 ± 0.17 cm2 and the mean left ventricular-aortic pressure gradient was 47.3±18.2 mmHg, with an STS score of 9.3% (4.8%-22.3%). The prostheses implanted were self-expanding in 97% of cases. Perioperative mortality was 1.5%; 30-day mortality, 5.9%; in-hospital mortality, 8.1%; and one-year mortality, 15.5%. Blood transfusion (relative risk of 54; p = 0.0003) and pulmonary arterial hypertension (relative risk of 5.3; p = 0.036) were predictive of in-hospital mortality. Peak C-reactive protein (relative risk of 1.8; p = 0.013) and blood transfusion (relative risk of 8.3; p = 0.0009) were predictive of 1-year mortality. At 30 days, 97% of patients were in NYHA functional class I/II; at one year, this figure reached 96%.

CONCLUSION

Transcatheter aortic valve implantation was performed with a high success rate and low mortality. Blood transfusion was associated with higher in-hospital and one-year mortality. Peak C-reactive protein was associated with one-year mortality.

Для цитирования: Souza André Luiz Silveira, Salgado Constantino González, Mourilhe-Rocha Ricardo, Mesquita Evandro Tinoco, Lima Luciana Cristina Lima Correia, Mattos Nelson Durval Ferreira Gomes de, Rabischoffsky Arnaldo, Fagundes Francisco Eduardo Sampaio, Colafranceschi Alexandre Siciliano, Carvalho Luiz Antonio Ferreira. Transcatheter Aortic Valve Implantation and Morbidity and Mortality-Related Factors: a 5-Year Experience in Brazil.. Arquivos brasileiros de cardiologia. 2016. DOI: 10.5935/abc.20160072.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.